Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lotus Tissue Repair
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lotus Tissue Repair

Lotus Tissue Repair

Series A

Lotus Tissue Repair: Innovating skin tech for accelerated healing of chronic dermatologic conditions.

HQ
Cambridge, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees

Lotus Tissue Repair focuses on developing advanced skin technology to accelerate the healing of chronic dermatologic conditions, including foot ulcers. Their mission is to improve patient outcomes through innovative treatments that address persistent skin issues.

Key achievements include the development of proprietary wound healing technology that has shown promising results in clinical trials. The company has made significant strides in the dermatology market, positively impacting patients' lives with their cutting-edge solutions.

Lotus Tissue Repair - Similar Companies

WoundForce logo

WoundForce

RenovoDerm logo

RenovoDerm

Biowound Solutions logo

Biowound Solutions

BioTissue logo

BioTissue

biotissue.com

Blossom Innovations logo

Blossom Innovations

Emunamedica logo

Emunamedica

HekeTiss logo

HekeTiss

heketiss.ch

bTECH logo

bTECH

btechls.com

Eluciderm logo

Eluciderm

eluciderm.com

DermBiont logo

DermBiont

dermbiont.com

Follica logo

Follica

follicabio.com

Biofisica logo

Biofisica

biofisica.com

Distinct Dermatology logo

Distinct Dermatology

Dermal Life logo

Dermal Life

CarthroniX logo

CarthroniX

carthronix.com

Lotus Tissue Repair - Quick Facts

Who are Lotus Tissue Repair's competitors?

Companies similar to Lotus Tissue Repair include WoundForce, RenovoDerm, Biowound Solutions and BioTissue.

When was Lotus Tissue Repair founded?

Lotus Tissue Repair was founded in 2010.

Where is Lotus Tissue Repair's headquarters located?

Lotus Tissue Repair's headquarters is located in Cambridge, MA, US.

When was Lotus Tissue Repair's last funding round?

Lotus Tissue Repair's most recent funding round was for $26M (USD) in June 2011.

How much has Lotus Tissue Repair raised to-date?

As of Jun 30, 2011, Lotus Tissue Repair has raised a total of $26M (USD).

How many employees does Lotus Tissue Repair have?

Lotus Tissue Repair has 30 employees as of Feb 5, 2024.

Lotus Tissue Repair - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Skin Technology
  • Wound Healing
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research